Cardio-Oncology in Era of the COVID-19 Pandemic and Beyond.
Identifieur interne : 000012 ( Main/Corpus ); précédent : 000011; suivant : 000013Cardio-Oncology in Era of the COVID-19 Pandemic and Beyond.
Auteurs : Daniel Addison ; Courtney M. Campbell ; Avirup Guha ; Arjun K. Ghosh ; Susan F. Dent ; Hani JneidSource :
- Journal of the American Heart Association [ 2047-9980 ] ; 2020.
Abstract
Coronavirus 2019 (COVID-19) has emerged as a global pandemic and public health crisis. Increasing waves of intermittent infectious outbreaks have dramatically influenced care among broad populations. Over the last two decades, there has been a rapid increase in cancer survival, with >400,000 new survivors each year. The increasingly common presence of cardiovascular disease in patients during or after cancer treatment led to the rapid growth of the field of cardio-oncology with a mandate of identifying, treating, and preventing the various forms of cardiovascular disease seen among this population. This review evaluates the implications of the pandemic on the practice and study of cardio-oncology. The evolving understanding of the relationship between comorbid disease and clinical outcomes among this population is assessed. With the impetus of the pandemic, cardio-oncology can be deliberate in embracing changes to cardiac screening, monitoring, and intervention during oncology care. Bridging two specialties, consideration of the lessons learned in cancer and cardiovascular may pivotally inform ongoing therapeutic efforts. Further, the development of multi-center registries focused on understanding and optimizing outcomes among these patients should be considered. Together, these insights may critically inform strategies for the care of cardio-oncology patients in future phases of the COVID-19 pandemic and beyond.
DOI: 10.1161/JAHA.120.017787
PubMed: 32713239
Links to Exploration step
pubmed:32713239Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cardio-Oncology in Era of the COVID-19 Pandemic and Beyond.</title><author><name sortKey="Addison, Daniel" sort="Addison, Daniel" uniqKey="Addison D" first="Daniel" last="Addison">Daniel Addison</name><affiliation><nlm:affiliation>Cardio-Oncology Program Division of Cardiology Department of Internal Medicine The Ohio State University Medical Center Columbus OH United States.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cancer Prevention and Control Department of Internal Medicine College of Medicine The Ohio State University Columbus OH United States.</nlm:affiliation></affiliation></author><author><name sortKey="Campbell, Courtney M" sort="Campbell, Courtney M" uniqKey="Campbell C" first="Courtney M" last="Campbell">Courtney M. Campbell</name><affiliation><nlm:affiliation>Cardio-Oncology Program Division of Cardiology Department of Internal Medicine The Ohio State University Medical Center Columbus OH United States.</nlm:affiliation></affiliation></author><author><name sortKey="Guha, Avirup" sort="Guha, Avirup" uniqKey="Guha A" first="Avirup" last="Guha">Avirup Guha</name><affiliation><nlm:affiliation>Cardio-Oncology Program Division of Cardiology Department of Internal Medicine The Ohio State University Medical Center Columbus OH United States.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Harrington Heart and Vascular Institute Case Western Reserve University Cleveland OH United States.</nlm:affiliation></affiliation></author><author><name sortKey="Ghosh, Arjun K" sort="Ghosh, Arjun K" uniqKey="Ghosh A" first="Arjun K" last="Ghosh">Arjun K. Ghosh</name><affiliation><nlm:affiliation>Cardio-Oncology Service Bart's Heart Centre St. Bartholomew's Hospital West Smithfield London United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Dent, Susan F" sort="Dent, Susan F" uniqKey="Dent S" first="Susan F" last="Dent">Susan F. Dent</name><affiliation><nlm:affiliation>Cardio-Oncology Program Division of Medical Oncology Department of Internal Medicine Duke University Durham NC United States.</nlm:affiliation></affiliation></author><author><name sortKey="Jneid, Hani" sort="Jneid, Hani" uniqKey="Jneid H" first="Hani" last="Jneid">Hani Jneid</name><affiliation><nlm:affiliation>Division of Cardiology Baylor College of Medicine Michael E. DeBakey VA Medical Center Houston TX United States.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32713239</idno><idno type="pmid">32713239</idno><idno type="doi">10.1161/JAHA.120.017787</idno><idno type="wicri:Area/Main/Corpus">000012</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000012</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cardio-Oncology in Era of the COVID-19 Pandemic and Beyond.</title><author><name sortKey="Addison, Daniel" sort="Addison, Daniel" uniqKey="Addison D" first="Daniel" last="Addison">Daniel Addison</name><affiliation><nlm:affiliation>Cardio-Oncology Program Division of Cardiology Department of Internal Medicine The Ohio State University Medical Center Columbus OH United States.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Division of Cancer Prevention and Control Department of Internal Medicine College of Medicine The Ohio State University Columbus OH United States.</nlm:affiliation></affiliation></author><author><name sortKey="Campbell, Courtney M" sort="Campbell, Courtney M" uniqKey="Campbell C" first="Courtney M" last="Campbell">Courtney M. Campbell</name><affiliation><nlm:affiliation>Cardio-Oncology Program Division of Cardiology Department of Internal Medicine The Ohio State University Medical Center Columbus OH United States.</nlm:affiliation></affiliation></author><author><name sortKey="Guha, Avirup" sort="Guha, Avirup" uniqKey="Guha A" first="Avirup" last="Guha">Avirup Guha</name><affiliation><nlm:affiliation>Cardio-Oncology Program Division of Cardiology Department of Internal Medicine The Ohio State University Medical Center Columbus OH United States.</nlm:affiliation></affiliation><affiliation><nlm:affiliation>Harrington Heart and Vascular Institute Case Western Reserve University Cleveland OH United States.</nlm:affiliation></affiliation></author><author><name sortKey="Ghosh, Arjun K" sort="Ghosh, Arjun K" uniqKey="Ghosh A" first="Arjun K" last="Ghosh">Arjun K. Ghosh</name><affiliation><nlm:affiliation>Cardio-Oncology Service Bart's Heart Centre St. Bartholomew's Hospital West Smithfield London United Kingdom.</nlm:affiliation></affiliation></author><author><name sortKey="Dent, Susan F" sort="Dent, Susan F" uniqKey="Dent S" first="Susan F" last="Dent">Susan F. Dent</name><affiliation><nlm:affiliation>Cardio-Oncology Program Division of Medical Oncology Department of Internal Medicine Duke University Durham NC United States.</nlm:affiliation></affiliation></author><author><name sortKey="Jneid, Hani" sort="Jneid, Hani" uniqKey="Jneid H" first="Hani" last="Jneid">Hani Jneid</name><affiliation><nlm:affiliation>Division of Cardiology Baylor College of Medicine Michael E. DeBakey VA Medical Center Houston TX United States.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of the American Heart Association</title><idno type="eISSN">2047-9980</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Coronavirus 2019 (COVID-19) has emerged as a global pandemic and public health crisis. Increasing waves of intermittent infectious outbreaks have dramatically influenced care among broad populations. Over the last two decades, there has been a rapid increase in cancer survival, with >400,000 new survivors each year. The increasingly common presence of cardiovascular disease in patients during or after cancer treatment led to the rapid growth of the field of cardio-oncology with a mandate of identifying, treating, and preventing the various forms of cardiovascular disease seen among this population. This review evaluates the implications of the pandemic on the practice and study of cardio-oncology. The evolving understanding of the relationship between comorbid disease and clinical outcomes among this population is assessed. With the impetus of the pandemic, cardio-oncology can be deliberate in embracing changes to cardiac screening, monitoring, and intervention during oncology care. Bridging two specialties, consideration of the lessons learned in cancer and cardiovascular may pivotally inform ongoing therapeutic efforts. Further, the development of multi-center registries focused on understanding and optimizing outcomes among these patients should be considered. Together, these insights may critically inform strategies for the care of cardio-oncology patients in future phases of the COVID-19 pandemic and beyond.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32713239</PMID><DateRevised><Year>2020</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Jul</Month><Day>27</Day></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>Cardio-Oncology in Era of the COVID-19 Pandemic and Beyond.</ArticleTitle><Pagination><MedlinePgn>e05456</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.120.017787</ELocationID><Abstract><AbstractText>Coronavirus 2019 (COVID-19) has emerged as a global pandemic and public health crisis. Increasing waves of intermittent infectious outbreaks have dramatically influenced care among broad populations. Over the last two decades, there has been a rapid increase in cancer survival, with >400,000 new survivors each year. The increasingly common presence of cardiovascular disease in patients during or after cancer treatment led to the rapid growth of the field of cardio-oncology with a mandate of identifying, treating, and preventing the various forms of cardiovascular disease seen among this population. This review evaluates the implications of the pandemic on the practice and study of cardio-oncology. The evolving understanding of the relationship between comorbid disease and clinical outcomes among this population is assessed. With the impetus of the pandemic, cardio-oncology can be deliberate in embracing changes to cardiac screening, monitoring, and intervention during oncology care. Bridging two specialties, consideration of the lessons learned in cancer and cardiovascular may pivotally inform ongoing therapeutic efforts. Further, the development of multi-center registries focused on understanding and optimizing outcomes among these patients should be considered. Together, these insights may critically inform strategies for the care of cardio-oncology patients in future phases of the COVID-19 pandemic and beyond.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Addison</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardio-Oncology Program Division of Cardiology Department of Internal Medicine The Ohio State University Medical Center Columbus OH United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cancer Prevention and Control Department of Internal Medicine College of Medicine The Ohio State University Columbus OH United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Courtney M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Cardio-Oncology Program Division of Cardiology Department of Internal Medicine The Ohio State University Medical Center Columbus OH United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guha</LastName><ForeName>Avirup</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardio-Oncology Program Division of Cardiology Department of Internal Medicine The Ohio State University Medical Center Columbus OH United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Harrington Heart and Vascular Institute Case Western Reserve University Cleveland OH United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghosh</LastName><ForeName>Arjun K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Cardio-Oncology Service Bart's Heart Centre St. Bartholomew's Hospital West Smithfield London United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dent</LastName><ForeName>Susan F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Cardio-Oncology Program Division of Medical Oncology Department of Internal Medicine Duke University Durham NC United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jneid</LastName><ForeName>Hani</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Cardiology Baylor College of Medicine Michael E. DeBakey VA Medical Center Houston TX United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">Cancer</Keyword><Keyword MajorTopicYN="N">Cardiac Imaging</Keyword><Keyword MajorTopicYN="N">Cardio‐Oncology</Keyword><Keyword MajorTopicYN="N">Targeted Therapies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32713239</ArticleId><ArticleId IdType="doi">10.1161/JAHA.120.017787</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000012 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000012 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CardioCovidV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32713239
|texte= Cardio-Oncology in Era of the COVID-19 Pandemic and Beyond.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32713239" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CardioCovidV1
| This area was generated with Dilib version V0.6.35. |  |